期刊文献+

人I型干扰素受体亚基稳定表达真核细胞的筛选及鉴定 被引量:1

Construction of pcDNA3.1-IFNAR1 Eukaryotic Expression Plasmid and its Expression in HepG2 Cell Lines
下载PDF
导出
摘要 目的:筛选及鉴定人I型干扰素受体亚基(IFNAR1)稳定表达真核细胞。方法:体外扩增IFNAR1基因片段,将双酶切后扩增片段和pc DNA3.1(+)连接构建重组质粒pc DNA3.1-IFNAR1,转化BL21感受态细菌培养,提取重组质粒行琼脂糖凝胶电泳和测序鉴定。重组质粒pc DNA3.1-IFNAR1转染肝癌细胞系Hep G2,新霉素筛选挑取阳性克隆细胞,蛋白质印迹试验(Western blotting)分析阳性细胞IFNAR1表达水平。结果:经双酶切和测序验证pc DNA3.1-IFNAR1重组质粒构建成功。pc DNA3.1-IFNAR1转染Hep G2经新霉素筛选后获得稳定表达细胞系,蛋白质印迹试验(Western blotting)证实这些细胞具有较好蛋白表达水平。结论:体外成功构建不同IFNAR1稳定表达水平的Hep G2细胞。 Objective To identify the expression of IFNAR1 in Human hepG2 cells and detected its expression. MethodsThe full-length IFNAR1 cDNA gene in HepG2 cell lines was amplified by RT-PCR and then integrated into pcDNA3.1(+) to construct the expression vector pc DNA3.1-IFNAR1. Subsequently,the pc DNA3.1-IFNAR1 was transfected into HepG2 cell and selected with neomycin. The positive cell clones were picked up and the expression of IFNAR1 protein was detected by western blotting method. Results pc DNA3.1-IFNAR1 was successfully constructed and demonstrated by agrose electrophoresis and sequencing. The different expression of IFNAR1 protein was verifi ed in stable HepG2 cells. Conclusion IFNAR1 protein can stably be expressed in HepG2 cells transfected with pc DNA3.1- IFNAR1 vector.
出处 《深圳中西医结合杂志》 2015年第1期4-6,共3页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
基金 深圳市科技创新委员会重点学科经费课题(JCYJ 20130402151227167)
关键词 人I型干扰素受体亚基 IFNAR1基因 重组质粒 稳定表达 真核细胞 IFNAR1 IFNAR1 gene Recombinant plasmid Stable expression Eukaryotic cells
  • 相关文献

同被引文献9

  • 1Dde Weerd NA, Samarajiwa SA, Hertzog PJ. Type I interferon recep- tors: biochemistry andbiological functions[J]. J Biol Chem,2007, 282: 20053-20057.
  • 2Schreiber G, Garcia KC. Structural linkage between ligand discrimina- tion and receptor activation by type i interferons[J]. Cell, 2011,146: 621.
  • 3Sugiyama M, Tanaka Y, Kato T, et al. Influence of hepatitis B virus gen- otypes on the intra and extracellular expression of viral DNA and anti- gens[J]. Hepatology, 2006, 44(4) : 915- 924.
  • 4Rosler C1, KOck J, Kann M, et al. APOBEC- mediated interference with hepadnavirus production[J].Hepatology,2005,42 (2): 301-309.
  • 5Tian Y, Chen WL, Ou JH. Effects of interferon-call3 on HBV replica- tion determined by viral load[J]. PeoS Pathog,2011,7(7):1002159.
  • 6Uze G, Schreiber G, Piehler J, et al.The receptor of the type I interferon family[J]. Curr Top Microbiol Immunol, 2007,316:71-95.
  • 7Takaoka A, Yanai H. Interferon signalling network in innate defence[J]. Cell Microbiol,2006,8(6): 907-922.
  • 8Uze G, Schreiber G, Piehler J, et al. The receptor of the type I interfer- on family[J]. Curr Top Microbiol Immunol,2007,316:71-95.
  • 9Kalie E, Jaitin DA, Podoplelova Y, et al. The stability of the ternaryin- terferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities[J]. J Biol Chem, 2008, 283(47) : 32925-32936.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部